Pleural Effusion
Classification
• Transudates (low protein, <30 g/L)
o Causes:
Heart failure (most common)
Hypoalbuminaemia (e.g., nephrotic syndrome, liver cirrhosis)
Constrictive pericarditis
• Exudates (high protein, >30 g/L)
o Causes:
Infection (parapneumonic, TB)
Malignancy (lung, breast, lymphoma)
Pulmonary embolism
Connective tissue disease (RA, SLE)
Light’s Criteria (exudate if any are true)
• Pleural fluid protein / serum protein >0.5
• Pleural fluid LDH / serum LDH >0.6
• Pleural fluid LDH > two-thirds upper limit of serum normal
Investigations
• CXR: blunting of costophrenic angle; lateral decubitus film shows layering
• Ultrasound: guides aspiration
• Diagnostic tap:
o pH <7.2 → empyema
o Low glucose → RA, empyema, TB, malignancy
o High amylase → pancreatitis, oesophageal rupture
Management
• Drainage if large, symptomatic, or infected (empyema)
• Treat underlying cause
Pneumothorax
Types
• Primary spontaneous pneumothorax (PSP)
o Typically young, tall, thin men
o Subpleural blebs rupture
• Secondary spontaneous pneumothorax (SSP)
o Occurs with underlying lung disease (COPD, ILD, CF)
• Traumatic/iatrogenic
o E.g., central line insertion, positive-pressure ventilation
Tension Pneumothorax
• Severe breathlessness, hypotension, tracheal deviation away, hyperresonant
• Emergency: immediate needle decompression
o Large bore cannula in 2nd ICS midclavicular line, then insert chest drain (5th ICS midaxillary line)
Management (British Thoracic Society)
• PSP
o <2 cm and no breathlessness → observe
o 2 cm or symptomatic → aspirate first, then drain if unsuccessful
• SSP
o 2 cm or symptomatic → chest drain
o <1 cm and asymptomatic → consider oxygen and observe
Mesothelioma
Features
• Malignant pleural tumour; strongly linked to asbestos exposure
• Long latency (~30–40 years)
Clinical
• Dyspnoea, pleuritic chest pain
• Recurrent unilateral pleural effusion
• Weight loss
Imaging
• CXR: unilateral effusion, pleural thickening, calcified pleural plaques (old asbestos exposure)
• CT: helps assess local invasion
Diagnosis
• Pleural fluid cytology (low yield)
• Thoracoscopic biopsy (definitive)
Prognosis
• Very poor; median survival ~12 months
Management
• Mainly palliative: pleurodesis, analgesia
• Chemotherapy (pemetrexed + cisplatin)
Extra Revision Pearls
• Transudate clues → systemic causes (e.g., HF, cirrhosis)
• Low pleural glucose → RA, empyema, TB, cancer
• High pleural amylase → think pancreatitis or oesophageal rupture
• Tension pneumothorax = clinical diagnosis → do not wait for CXR!
• Trachea deviates away from tension pneumothorax; towards collapse/effusion
• Asbestos exposure + recurrent effusion → mesothelioma until proven otherwise
• Bilateral pleural plaques → classic marker of asbestos exposure